Scotiabank Initiates Coverage On Apotex Health with Sector Outperform Rating, Announces Price Target of C$40

Scotiabank analyst Louise Chen initiates coverage on Apotex Health (TSX:APTX) with a Sector Outperform rating and announces Price Target of C$40.